GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chengdu Huasun Technology Group Inc Ltd (SZSE:000790) » Definitions » Revenue

Chengdu Huasun Technology Group (SZSE:000790) Revenue : ¥962.4 Mil (TTM As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Chengdu Huasun Technology Group Revenue?

Chengdu Huasun Technology Group's revenue for the three months ended in Mar. 2024 was ¥179.3 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥962.4 Mil. Chengdu Huasun Technology Group's Revenue per Share for the three months ended in Mar. 2024 was ¥0.28. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.38.

Warning Sign:

Chengdu Huasun Technology Group Inc Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Chengdu Huasun Technology Group was -10.80% per year. During the past 3 years, the average Revenue per Share Growth Rate was 6.10% per year. During the past 5 years, the average Revenue per Share Growth Rate was 7.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Chengdu Huasun Technology Group's highest 3-Year average Revenue per Share Growth Rate was 36.70% per year. The lowest was -7.20% per year. And the median was 9.00% per year.


Chengdu Huasun Technology Group Revenue Historical Data

The historical data trend for Chengdu Huasun Technology Group's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chengdu Huasun Technology Group Revenue Chart

Chengdu Huasun Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 745.34 759.31 954.69 873.10 1,003.38

Chengdu Huasun Technology Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 220.29 262.77 189.40 330.92 179.28

Competitive Comparison of Chengdu Huasun Technology Group's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Chengdu Huasun Technology Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chengdu Huasun Technology Group's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chengdu Huasun Technology Group's Revenue distribution charts can be found below:

* The bar in red indicates where Chengdu Huasun Technology Group's Revenue falls into.



Chengdu Huasun Technology Group Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥962.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chengdu Huasun Technology Group  (SZSE:000790) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Chengdu Huasun Technology Group Revenue Related Terms

Thank you for viewing the detailed overview of Chengdu Huasun Technology Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Chengdu Huasun Technology Group (SZSE:000790) Business Description

Traded in Other Exchanges
N/A
Address
1168 Fuxin Avenue, High-tech Zone (West District), No. 101, 1st Floor, Building 2, Sichuan, Chengdu, CHN, 611731
Chengdu Huasun Technology Group Inc Ltd, formerly Chengdu Taihe Health Technology Group Inc Ltd is engaged in the production and distribution of traditional Chinese medicines and chemical drugs in China. It is also involved in veterinary drugs, biological vaccines, and modern steel products.
Executives
Huang Xue Director
Wang Ren Guo Directors, executives
Ye Jing Executives
Jiang Li Executives
Bo Jian Ping Executives
Wang Tian Xiang Executives
Tang Ji Ying Executives
Li Jian Hua Executives
Wan Fang Executives
Wei Yi Guo Executives
Chen Zhong Qiao Director

Chengdu Huasun Technology Group (SZSE:000790) Headlines

No Headlines